Allergen immunotherapy in the polyallergic adolescent
Medica Jadertina · 2022
DOI: 10.57140/mj.52.3.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medica Jadertina, 2022. Verfasst von Vesna Vukičević Lazarević und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Allergen immunotherapy is the only disease-modifying treatment option for allergic rhinitis, with adherence being its major limitation. We report a case of an adolescent with rhinitis, proven allergy to multiple non-homologous pollens, and troublesome symptoms despite maximal symptomatic therapy during the late spring and early summer months. Allergen immunotherapy to the most clinically relevant allergen was initiated under the supervision of a pediatrician. Shortly before her second year of treatment, she transferred to adult care and maintained a high degree of adherence and a favourable response to immunotherapy. In conclusion, allergen immunotherapy is effective in polyallergic adolescents with good adherence.
Zitieren
APA
Lazarević, V. V., Šola, A. M., & Marković, I. (2022). Allergen immunotherapy in the polyallergic adolescent. Medica Jadertina. https://doi.org/10.57140/mj.52.3.4
Vancouver
Lazarević VV, Šola AM, Marković I. Allergen immunotherapy in the polyallergic adolescent. Medica Jadertina. 2022. doi:10.57140/mj.52.3.4
BibTeX
@article{Lazarevi2022,
author = {Lazarević, Vesna Vukičević and Šola, Ana Marija and Marković, Ivan},
title = {Allergen immunotherapy in the polyallergic adolescent},
journal = {Medica Jadertina},
year = {2022},
doi = {10.57140/mj.52.3.4}
}
EUVIMED